TerrAscend Corp. (OTCMKTS:TRSSF - Get Free Report) shares rose 0.3% on Friday . The company traded as high as $0.27 and last traded at $0.26. Approximately 303,284 shares were traded during mid-day trading, an increase of 131% from the average daily volume of 131,026 shares. The stock had previously closed at $0.26.
TerrAscend Stock Performance
The company has a debt-to-equity ratio of 0.55, a current ratio of 0.73 and a quick ratio of 0.40. The stock's 50 day simple moving average is $0.33 and its two-hundred day simple moving average is $0.46.
TerrAscend Company Profile
(
Get Free Report)
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider TerrAscend, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.
While TerrAscend currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
